Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 32, Issue 6, 1996, Pages 345-360

  Matsuzaki, Koichi ^a,b   Kan, Mikio ^a   McKeehan, Wallace L ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

cancer; cytokines; growth factors; signal transduction

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BACULOVIRUS; BINDING AFFINITY; COMPLEX FORMATION; EXPRESSION VECTOR; LIGAND BINDING; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

INSECTA; MAMMALIA; UNIDENTIFIED BACULOVIRUS;

EID: 0029787215     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02722961     Document Type: Article

References (44)

1. Amatayakul-Chantler, S.; Qian, S. W.; Gakenheimer, K., et al. [Ser77]Transforming growth factor-β1. J. Biol. Chem. 269:27687-27691; 1994.
2. Attisano, L.; Carcamo, J.; Ventura, F., et al. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-680; 1993.
3. Bassing, C. H.; Yingling, J. M.; Howe, D. J., et al. A transforming growth factor β type I receptor that signals to activate gene expression. Science 263:87-89; 1994.
4. Brand, T.; MacLellan, W. R.; Schneider, M. D. A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J. Biol. Chem. 268:11500-11503; 1993.
5. Brunner, A. M.; Lioubin, M. N.; Marquardt, H., et al. Glycosylation sites in the transforming growth factor-β1 (TGFβ1) and TGFβ2 (414) precursors and of cysteine residues within mature TGFβ1: effects on secretion and bioactivity. Mol. Endocrinol. 6:1691-1700; 1992.
6. Carcamo, J.; Weis, F. M. B.; Ventura, F., et al. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14:3810-3821; 1994.
7. Chen, R.-H.; Derynck, R. Homomeric interactions between type II transforming growth factor-β receptors. J. Biol. Chem. 269:22868-22874; 1994.
8. Chen, F.; Weinberg, R. A. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Natl. Acad. Sci. USA 92:1565-1569; 1995.
9. Daopin, S.; Piez, K. A.; Ogawa, Y., et al. Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science 257:369-373; 1992.
10. Derynck, R. TGF-β-receptor-mediated signaling. Trends Biochem. Sci. 19:548-553; 1994.
11. Ebner, R.; Chen, R.-H.; Shum, L, et al. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260:1344-1348; 1993.
12. Estevez, M.; Attisano, L; Wrana, J. L., et al. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature 365:644-649; 1993.
13. Franzen, P.; ten Dijke, P.; Ichijo, H., et al. A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. Cell 75:681-692; 1993.
14. Fukushima, D.; Butzow, R.; Hildebrand, A., et al. Localization of transforming growth factor β binding site in betaglycan. J. Biol. Chem. 268:22710-22715; 1993.
15. Gougos, A.; Letarte, M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 265:8361-8364; 1990.
16. He, W. W.; Gustafson, M. L.; Hirobe, S., et al. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-β type II receptor family. Dev. Dyn. 196:133-142; 1993.
17. Henis, Y. I.; Moustakas, A.; Lin, H. Y., et al. The types II and III transforming growth factor-β receptors form homo-oligomers. J. Cell Biol. 126:139-154; 1994.
18. Husken-Hindi, P.; Tsuchida, K.; Park, M., et al. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J. Biol. Chem. 269:19380-19384; 1994.
19. Inagaki, M.; Moustakas, A.; Lin, H. Y., et al. Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc. Nati. Acad. Sci. USA 90:5359-5363; 1993.
20. Laiho, M.; Weis, F. M. B.; Massague, J. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265:18518-18524; 1990.
21. Lin, H. Y.; Moustakas, A.; Knaus, P., et al. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor. J. Biol. Chem. 270:2747-2754; 1995.
22. Lin, H. Y.; Wang, X.-F.; Ng-Eaton, E., et al. Expression cloning of the TGF-β receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785; 1992.
23. Lopez-Casillas, F.; Cheifetz, S.; Doody, J., et al. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67:785-795; 1991.
24. Lopez-Casillas, F.; Payne, H. M.; Andres, J. L, et al. Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124:557-568; 1994.
25. Lopez-Casillas, F.; Wrana, J. L.; Massague, J. Betaglycan presents ligand to the TGFβ signaling receptor. Cell 73:1435-1444; 1993.
26. Massague, J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:597-641; 1990.
27. Massague, J.; Like, B. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem. 260:2636-2645; 1985.
28. Mathews, L. S.; Vale, W. W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982; 1991.
29. Matsuzaki, K.; Xu, J.; Wang, F., et al. A widely-expressed serine/threonine kinase receptor that does not bind activin, inhibin, transforming growth factor beta or bone morpbogenic factor. J. Biol. Chem. 268:12719-12723; 1993.
30. Moustakas, A.; Lin, H. Y.; Henis, Y. I., et al. The transforming growth factor β receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. J. Biol. Chem. 268:22215-22218; 1993.
31. Pepin, M.-C.; Beauchemin, M.; Plamondon, J., et al. Mapping of the ligand binding domain of the transforming growth factor β receptor type III by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 91:6997-7001; 1994.
32. Roberts, A. B.; Sporn, M. B. The transforming growth factor-βs. In: Sporn, M. B.; Roberts, A. B., eds. Peptide growth factors and their receptors. Berlin: Springer-Verlag; 1990:419-472.
33. Shi, E.; Kan, M.; Xu, J., et al. Control of FGF receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol. Cell. Biol. 13:3907-3918; 1993.
34. ten Dijke, P.; Ichijo, H.; Franzen, P., et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8:2879-2887; 1993.
35. ten Dijke, P.; Yamashita, H.; Ichijo, H., et al. Characterization of type I receptors for transforming growth factor-β and activin. Science 264:101-104; 1994.
36. Tsuchida, K.; Mathews, L. S.; Vale, W. W. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc. Natl. Acad. Sci. USA 90:11242-11246; 1993.
37. Ventura, F.; Doody, J.; Liu, F., et al. Reconstitution and traasphosphorylation of TGF-β receptor complexes. EMBO J. 13:5581-5589; 1994.
38. Wang, X.-F.; Lin, H. Y.; Ng-Eaton, E., et al. Expression cloning and characterization of the TGF-beta type III receptor. Cell 67:797-805; 1991.
39. Wrana, J. L; Attisano, L.; Wieser, R., et al. Mechanism of activation of the TGF-β receptor. Nature 370:341-347; 1994.
40. Xu, J.; Matsuzaki, K.; McKeehan, K., et al. Genomic structure and cloned cDN As predict four variants in the kinase domain of serine/threonine kinase receptors arise by alternate splicing and poly(A) addition. Proc. Natl. Acad. Sci. USA 91:7957-7961; 1994.
41. Xu, J.; Nakahara, M.; Crabb, J. W., et al. Expression and immunochemical analysis of rat prostate and human heparin-binding fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem. 267:17792-17803; 1992.
42. Xu, J.; McKeehan, K.; Matsuzaki, K., et al. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J. Biol. Chem. 270:6308-6313; 1995.
43. Yamashita, H.; Hidenori, I.; Grimsby, S., et al. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J. Biol. Chem. 269:1995-2001; 1994a.
44. Yamashita, H.; ten Dijke, P.; Franzen, P., et al. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem. 269:20172-20178; 1994b.